Sicart Associates LLC Guardant Health, Inc. Transaction History

Sicart Associates LLC

  • $346 Million
  • Q4 2025

A detailed history of Sicart Associates LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sicart Associates LLC holds 228,203 shares of GH stock, worth $21.5 Million. This represents 6.22% of its overall portfolio holdings.

Number of Shares
228,203
Previous 230,083 0.82%
Holding current value
$21.5 Million
Previous $14.4 Million 49.81%
% of portfolio
6.22%
Previous 4.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026
SELL
$61.46 - $98.92 $115,544 - $185,969
-1,880 Reduced 0.82%
228,203 $21.5 Million
Q3 2025

Oct 07, 2025
BUY
$40.98 - $67.42 $2.65 Million - $4.36 Million
64,628 Added 39.06%
230,083 $14.4 Million
Q2 2025

Jul 18, 2025
BUY
$37.05 - $52.04 $1.03 Million - $1.45 Million
27,862 Added 20.25%
165,455 $8.61 Million
Q1 2025

Apr 24, 2025
SELL
$31.77 - $49.94 $87,049 - $136,835
-2,740 Reduced 1.95%
137,593 $5.86 Million
Q4 2024

Jan 14, 2025
SELL
$20.2 - $38.11 $120,594 - $227,516
-5,970 Reduced 4.08%
140,333 $4.29 Million
Q3 2024

Oct 25, 2024
BUY
$22.3 - $36.29 $7,136 - $11,612
320 Added 0.22%
146,303 $3.35 Million
Q2 2024

Aug 02, 2024
SELL
$16.07 - $31.84 $9,786 - $19,390
-609 Reduced 0.42%
145,983 $4.22 Million
Q1 2024

May 02, 2024
BUY
$17.13 - $26.91 $918,836 - $1.44 Million
53,639 Added 57.71%
146,592 $3.02 Million
Q4 2023

Jan 19, 2024
SELL
$21.58 - $29.5 $64,135 - $87,674
-2,972 Reduced 3.1%
92,953 $2.51 Million
Q3 2023

Oct 25, 2023
BUY
$25.8 - $39.97 $76,239 - $118,111
2,955 Added 3.18%
95,925 $2.84 Million
Q2 2023

Jul 28, 2023
BUY
$20.94 - $38.01 $63,867 - $115,930
3,050 Added 3.39%
92,970 $3.33 Million
Q1 2023

May 09, 2023
SELL
$22.92 - $33.76 $184,964 - $272,443
-8,070 Reduced 8.24%
89,920 $2.11 Million
Q4 2022

Jan 27, 2023
SELL
$25.44 - $59.78 $978,651 - $2.3 Million
-38,469 Reduced 28.19%
97,990 $0
Q3 2022

Nov 01, 2022
SELL
$43.66 - $61.0 $62,433 - $87,230
-1,430 Reduced 1.04%
136,459 $7.35 Million
Q2 2022

Aug 05, 2022
BUY
$28.82 - $77.35 $121,706 - $326,649
4,223 Added 3.16%
137,889 $5.56 Million
Q1 2022

May 06, 2022
BUY
$48.25 - $100.49 $4.43 Million - $9.22 Million
91,783 Added 219.14%
133,666 $8.85 Million
Q4 2021

Jan 31, 2022
BUY
$88.71 - $120.43 $3,637 - $4,937
41 Added 0.1%
41,883 $4.2 Million
Q3 2021

Oct 22, 2021
BUY
$98.77 - $132.17 $130,573 - $174,728
1,322 Added 3.26%
41,842 $5.23 Million
Q2 2021

Jul 23, 2021
BUY
$109.77 - $165.68 $4.45 Million - $6.71 Million
40,520 New
40,520 $5.03 Million

Others Institutions Holding GH

# of Institutions
459
Shares Held
125M
Call Options Held
2.18M
Put Options Held
2.69M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $9.65B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email